ImCheck Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ImCheck Therapeutics SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11124
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ImCheck Therapeutics SAS (ImCheck Therapeutics) is an independent biotechnology company that develops drugs for cancer and auto-immune disorders. The company is developing two first-in-class immunomodulator antibodies that are effective against adaptive and innate immunity to treat cancer and other immune related diseases. It works in collaboration with institutions and academics to develop precision & personalized medicines. The company is a spin-off from Marseille’s Institut Paoli-Calmettes. ImCheck Therapeutics is headquartered in Marseille, France.

ImCheck Therapeutics SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ImCheck Therapeutics SAS, Medical Devices Deals, 2012 to YTD 2018 9
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
ImCheck Therapeutics Raises USD21.8 Million in Series A Financing 11
Kurma Partners Invests in Imcheck Therapeutics 13
Licensing Agreements 14
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 14
Equity Offering 15
ImCheck Therapeutics Spin Out from Institut Paoli-Calmettes 15
ImCheck Therapeutics SAS – Key Competitors 16
ImCheck Therapeutics SAS – Key Employees 17
ImCheck Therapeutics SAS – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Sep 12, 2018: Imcheck Therapeutics appoints Prof. Rene Hoet, Phd, as Chief Scientific Officer 19
May 25, 2018: ImCheck Therapeutics Names Dr. Debasish Roychowdhury As Independent Board Chairman 20
May 02, 2017: ImCheck Therapeutics appoints its CEO 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Key Facts 2
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ImCheck Therapeutics SAS, Deals By Therapy Area, 2012 to YTD 2018 8
ImCheck Therapeutics SAS, Medical Devices Deals, 2012 to YTD 2018 9
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ImCheck Therapeutics Raises USD21.8 Million in Series A Financing 11
Kurma Partners Invests in Imcheck Therapeutics 13
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 14
ImCheck Therapeutics Spin Out from Institut Paoli-Calmettes 15
ImCheck Therapeutics SAS, Key Competitors 16
ImCheck Therapeutics SAS, Key Employees 17

List of Figures
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ImCheck Therapeutics SAS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[ImCheck Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PhaseRx Inc (PZRX)-製薬・医療分野:企業M&A・提携分析
    Summary PhaseRx Inc (PhaseRx), formerly PhaseRx Pharmaceuticals Inc is a healthcare products provider that conducts research and develops RNA nanomedicines for the treatment of orphan diseases. The company discovers and develops drugs based on SMARTT polymer technology, which offers mRNA delivery te …
  • PTT Public Co Ltd (PTT):石油・ガス:M&Aディール及び事業提携情報
    Summary PTT Public Co Ltd (PTT) is a state-owned integrated national oil and gas, and petrochemical company. It operates in oil and natural gas, coal, power, and infrastructure businesses. The company carries out oil and natural gas exploration and production; oil refining; procurement, processing, …
  • Magnolia Petroleum Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Magnolia Petroleum Plc (Magnolia Petroleum) is an oil and gas company. The company explores, acquires, and develops oil and natural gas properties. It holds interests in producing properties in two project areas such as Bakken shale in North Dakota and the proven Mississippi Lime, Woodford a …
  • Holland Colours NV (HOLCO):企業の財務・戦略的SWOT分析
    Holland Colours NV (HOLCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • FMR LLC:企業の戦略的SWOT分析
    FMR LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Evofem Biosciences Inc (EVFM):医療機器:M&Aディール及び事業提携情報
    Summary Evofem Biosciences Inc (Evofem) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes reproductive and contraceptive care products for women. The company’s lead product candidate includes Amphora, a non-hormonal vaginal contraceptive gel for the prevention …
  • Electra Ltd (ELTR):企業の財務・戦略的SWOT分析
    Electra Ltd (ELTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Talon Metals Corp.:企業の戦略・SWOT・財務分析
    Talon Metals Corp. - Strategy, SWOT and Corporate Finance Report Summary Talon Metals Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • PT PLN (Persero):企業の発電所・SWOT分析2018
    PT PLN (Persero) - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • New Age Metals Inc:企業の戦略・SWOT・財務分析
    New Age Metals Inc - Strategy, SWOT and Corporate Finance Report Summary New Age Metals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Telefonaktiebolaget LM Ericsson:企業の戦略・SWOT・財務情報
    Telefonaktiebolaget LM Ericsson - Strategy, SWOT and Corporate Finance Report Summary Telefonaktiebolaget LM Ericsson - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Banca Del Ceresio SA:企業の戦略・SWOT・財務分析
    Banca Del Ceresio SA - Strategy, SWOT and Corporate Finance Report Summary Banca Del Ceresio SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Heineken NV:戦略・SWOT・企業財務分析
    Heineken NV - Strategy, SWOT and Corporate Finance Report Summary Heineken NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Hexza Corporation Berhad (HEXZA):企業の財務・戦略的SWOT分析
    Hexza Corporation Berhad (HEXZA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Society for Worldwide Interbank Financial Telecommunication:企業の戦略的SWOT分析
    Society for Worldwide Interbank Financial Telecommunication - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, k …
  • Swiss AviationSoftware Ltd.:企業の戦略的SWOT分析
    Swiss AviationSoftware Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Adventist Health System-製薬・医療分野:企業M&A・提携分析
    Summary Adventist Health System (AHS) is a faith based medical health care organization. It serves through hospitals, nursing facilities and home care agencies. The organization, through its technologies and clinical research provide general medical care and specialized care for more than four milli …
  • Emcure Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Emcure Pharmaceuticals Ltd (Emcure) develops, manufactures and markets a range of pharmaceutical products worldwide. The company specializes in the development and manufacture of differentiated pharmaceutical products. It also manufactures active pharmaceutical ingredients (APIs) primarily f …
  • Breko GmbH:企業の戦略・SWOT・財務分析
    Breko GmbH - Strategy, SWOT and Corporate Finance Report Summary Breko GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • China Southern Airlines Company Limited:企業のM&A・事業提携・投資動向
    China Southern Airlines Company Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Southern Airlines Company Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed re …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆